W81XWH-17-T-0127-extend.docx
DOCX document 137 KB Posted
- Attached to
- Brand Name or Equal- Synthetic Cannabinoids Federal contract opportunity
- Solicitation number
- W81XWH-17-T-0127
- Issued by
- Department of the Army Medical Command
About this file
Extention
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| W81XWH-17-T-0127.docx | DOCX document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
W81XWH-17-T-0127
This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR 12.6, Streamlined Procedures for Commercial Items, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; Quotes are being requested and a written solicitation will not be issued. The solicitation number is W81XWH17T0127. The solicitation is issued as a request for quotation (RFQ). Provisions and clauses in effect through Federal Acquisition Circular 2005-95 are incorporated. It is the contractor’s responsibility to be familiar with the applicable clauses and provisions. The clauses may be accessed in full text at these addresses https://acquisition.gov/far/index.html and http://www.acq.osd.mil/dpap/sitemap.html. The NAICS code is 325199, with a small business size of 1,250 employees. This is a Full and Open Competition requirement; all qualified vendors are encouraged to submit a quote.
USAMRAA on behalf of the Armed Forces Medical Examiner System (AFMES) requests responses from qualified sources capable of providing Brand Name or Equal Synthetic Cannabinoids in accordance with the minimum essential characteristics (MECs), and Statement of Need (SON).
Est. Period of Performance:
Base Year – est: May 2, 2017 – May 1, 2018 Option Year 1 – est: May 2, 2018 – May 1, 2019 Option Year 2 – est. May 2, 2019 – May 1, 2020 Option Year 3 – est: May 2, 2020 – May 1, 2021 Option Year 4 – est: May 2, 2021 – May 1, 2022
MINIMUM ESSENTIAL CRITERIA
Mission Essential Characteristics Synthetic Cannabinoids
Background: The Armed Forces Medical Examiner System (AFMES) Division of Forensic Toxicology’s (DFT) primary function is to provide forensic toxicology testing and consultation for all Department of Defense (DoD) air, ground, and sea based mishap investigations, and criminal investigations. It also provides fitness for duty investigations, and medico-legal determinations (e.g., DUI) and other special cases of national interest. The laboratory serves as the central forensic toxicology laboratory for the entire DoD by providing drug analyses. In addition, the laboratory provides analysis on concentration determinations for therapeutic or toxic doses of drugs and special study investigations for emerging drugs of abuse. It is the only DoD laboratory capable of providing analytical testing for the newest and the fastest emerging drugs of abuse in the military – synthetic cannabinoids known as “Spice” and designer cathinones, known as “Bath Salts”. Spice and Bath Salt compounds are prohibited for use in the United States IAW 21 CFR Part 1308; however, they are controlled under the Drug Enforcement Administration (DEA), Schedule 1 controlled substance.
Purpose: Ampules containing neat solutions or dried material are used in the preparation of calibrators, standards and/or control materials. These materials are used to quantitate many of the frequently analyzed synthetic cannabinoids and also the non-frequently analyzed drugs reported by the AFMES. Additionally, material within the ampule is often used as reference material when obtaining full scan mass spectral data in medico-legal investigations. As a neat solution this material is assayed by gas chromatography/ mass spectrometry (GC/MS) Liquid Chromatography/ Mass Spectrometry (LC/MS), and Liquid Chromatography tandem mass spectrometry (LC/MS/MS). Material which is sealed in ampules and soluble in an organic solvent is also used as a retention time standard or markers when identifying compounds of interest when extracted from a biological matrix.
Specifications:
· Items are to be ordered on a continually “ as needed” basis.
· Ampules sizes vary but all must be shipped in and stored and packaged under nitrogen.
· The vendor will provide standard products as well as customized orders upon request for newly identified emerging drugs.
· Each compound must have a minimum purity standard of 98% and an analysis certification of a minimum of two chromatographic purity analyses.
· Each compound must be available in a minimum size of 500 µg thru the maximum size of 50 mg in addition to customized sizes upon request.
· Each compound must have a minimum of one-year stability from lot date; and must be able to store at -200C.
· All reference solutions must be weighed using the National Institute of Standards and Technology (NIST) standards.
· All reference standards must have at least a 6-month expiration date and shall bear the same lot number.
· Certificates of Analysis (COA) should be made available for each reference material batch along with the certified purity of the standard material.
· All chemical compound series (JWH, RCS, AM2, HU, WIN, and CP) and their types (Parent, Metabolites, Isomer, and Deuterated) shall be procured in accordance with the Drug Enforcement Administration (DEA) Schedule 1 (a category reserved for unsafe highly abused substances with no medical usage) controlled substances regulation.
Delivery Instructions: Deliveries will be made to 115 Purple Heart Drive, Dover AFB, Dover, DE 19902. The contractor will follow proper management, shipping and handling procedures in order to ensure product arrives in usable condition and are accepted by the COR.
Requirements: Below are some of the Synthetic Cannabinoids required to support our mission; however, we require a Blanket Purchase Agreement that will allow us to purchase from the entire catalog of Synthetic Cannabinoids:
| Item Name: | JWH 122 | |
| Description: | Synthetic cannabinoid (CB) of the naphthoylindole class is structurally related to |
JWH 018 and JWH 073. It displays high-affinities for both CB1 (Ki = 0.69 nM) and CB2 (Ki = 1.2 nM) receptors
| Formal Name: | (4-methyl-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)-methanone | ||
| Molecule Formula: | C25H25NO | ||
| Purity: | ≥ 98% | ||
| Shipping: | Room temperature |
| Item Name: | JWH 122-d9 | ||
| Description: | JWH 122-d9 contains nine deuterium atoms at the 2, 2’, 3, 3’, 4, 4’, 5, 5, and 5 positions. | ||
| Formal Name: | (4-methyl-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)-methanone-2,2',3,3',4,4',5,5,5-d9 | ||
| Formulation: | A solution in methanol | ||
| Purity: | ≥ 99% deuterated | ||
| Shipping: | Wet ice |
| Item Name: | JWH 122 N-(5-hydroxypentyl) metabolite | |
| Description: | Synthetic cannabinoid (CB) of the naphthoylindole class that is structurally |
related to JWH 018 and JWH 073. It displays high-affinities for both CB1 (Ki = 0.69 nM) and CB2 (Ki = 1.2 nM) receptors
| Formal Name: | (1-(5-hydroxypentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)-methanone | |||
| Molecule Formula: | C25H25NO2 | |||
| Purity: | ≥ 98% | |||
| Shipping: | Room temperature |
| Item Name: | RCS-4 | |||
| Description: | RCS-4 is a synthetic JWH 018 cannabinoid analog that has been identified as a Component of several different ‘herbal incense’ products | |||
| Formal Name: | (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone | |||
| Molecule Formula: | C21H23NO2 | |||
| Purity: | ≥ 98% | |||
| Shipping: | Room temperature |
| Item Name: | RCS-4-d9 | |||
| Description: | Contains nine deuterium atoms at the 2, 2’, 3, 3’, 4, 4’, 5, 5, and 5 positions. | |||
| Formal Name: | (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone-2,2',3,3',4,4',5,5,5-d9 | |||
| Molecule Formula: | C21H14D9NO2 | |||
| Purity: | ≥ 99% deuterated | |||
| Shipping: | Wet ice |
| Item Name: | RCS-4-N-(5-hydroxypentyl) metabolite | |
| Description: | Structurally similar to certain JWH compounds, synthetic cannabinoids used in herbal |
mixtures meant to mimic cannabis
| Formal Name: | (1-(5-hydroxypentyl)-1H-indol-3-yl)(4-methoxyphenyl)-methanone | ||
| Molecule Formula: | C21H23NO3 | ||
| Purity: | ≥ 98% | ||
| Shipping: | Room temperature |
| Item Name: | RCS-4-N-(4-hydroxypentyl) metabolite | ||
| Description: | RCS-4 is structurally similar to certain JWH compounds, synthetic cannabinoids used in herbal mixtures | ||
| Formal Name: | (1-(4-hydroxypentyl)-1H-indol-3-yl)(4-methoxyphenyl)methanone | ||
| Molecule Formula: | C21H33NO3 | ||
| Purity: | ≥ 98% | ||
| Shipping: | Room temp |
| Item Name: | RCS-4-N-(5-carboxypentyl) metabolite | |||
| Description: | RCS-4 N (5-carboxypentyl) metabolite is an expected metabolite of RCS-4 | |||
| Formal Name: | 5-(3-(4-methoxybenzoyl)-1H-indol-1-yl)pentanoic acid | |||
| Molecule Formula: | C21H21NO4 | |||
| Purity: | ≥ 98% | |||
| Shipping: | Room temperature |
| Item Name: | JWH 250 | |||
| Description: | A cannabimimetic indole that shows a high-affinity for both the central cannabinoid (CB1) and the peripheral cannabinoid (CB2) receptors | |||
| Formal Name: | 1-(1-pentyl-1H-indol-3-yl)-2-(2-methoxyphenyl)-ethanone | |||
| Molecule Formula: | C22H25NO2 | |||
| Purity: | ≥ 98% | |||
| Shipping: | Room temperature |
| Item Name: | JWH 250-d5 | |||
| Description: | Contains five deuterium atoms at the 2', 4' ,5', 6', and 7' positions. | |||
| Formal Name: | 1-(1-pentyl-1H-indol-3-yl)-2-(2-methoxyphenyl)-ethanone-2,4,5,6,7-d5 | |||
| Molecule Formula: | C22H20D5NO2 | |||
| Purity: | ≥ 99% deuterated | |||
| Shipping: | Wet ice |
| Item Name: | JWH 250 N-(4-hydroxypentyl) metabolite | |
| Description: | Synthetic cannabinoid (CB) which potently activates both CB1 and CB2 receptors (Ki values of 11 and 33 nM | |
| Formal Name: | 1-(1-(4-hydroxypentyl)-1H-indol-3-yl)-2-(2-methoxyphenyl)ethanone | |
| Formulation: | A crystalline solid | |
| Purity: | ≥ 98% | |
| Shipping: | Wet ice |
| Item Name: | JWH 250 N-( (pentanoic acid) metabolite | |||
| Description: | Cannabimimetic indoles, including certain “JWH” compounds, have been identified in herbal blends | |||
| Formal Name: | 5-(3-(2-(2-methoxyphenyl)acetyl)-1H-indol-1-yl)pentanoic acid | |||
| Molecule Formula: | C22H23NO4 | |||
| Purity: | ≥ 98% | |||
| Shipping: | Room temperature |
| Item Name: | JWH 250 N-(5-hydropentyl) metabolite | |||
| Description: | Cannabimimetic indoles, including certain JWH compounds, have been identified in herbal blends | |||
| Formal Name: | 1-(5-hydroxy-1-pentyl-1H-indol-3-yl)-2-(2-methoxyphenyl)ethanone | |||
| Molecule Formula: | C22H25NO3 | |||
| Purity: | ≥ 98% | |||
| Shipping: | Room temperature |
| Item Name: | JWH 210 | |||
| Description: | A potent cannabimimetic alkylindole, binding the central cannabinoid and peripheral | |||
| cannabinoid receptors with Ki values of 0.46 and 0.69 nM, | ||||
| Formal Name: | (4-ethyl-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)-methanone | |||
| Molecule Formula: | C26H27NO | |||
| Purity: | ≥ 98% | |||
| Shipping: | Room temperature |
| Item Name: | JWH 210-d9 | |||
| Description: | Contains nine deuterium atoms at the 2, 2’, 3, 3’, 4, 4’, 5, 5, and 5 positions. | |||
| Formal Name: | (4-ethyl-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)-methanone--d9 | |||
| Molecule Formula: | C26H10D9NO | |||
| Purity: | ≥ 99% | |||
| Shipping: | Wet ice |
| Item Name: | JWH 210 N-(pentanoic acid) metabolite | |||
| Description: | A potent cannabimimetic alkylindole that has been identified in extracts from herbal blends | |||
| Formal Name: | 3-[(4-ethyl-1-naphthalenyl)carbonyl]-1H-indole-1-pentanoic acid | |||
| Molecule Formula: | C26H25NO3 | |||
| Purity: | ≥ 98% | |||
| Shipping: | Room temperature |
| Item Name: | JWH 210 N-(5-hydroxypentyl) metabolite | |||
| Description: | A potent cannabimimetic alkylindole that has been identified in extracts from herbal blends | |||
| Formal Name: | (4-ethylnaphthalen-1-yl)(1-(5-hydroxypentyl)-1H-indol-3-yl)methanone | |||
| Molecule Formula: | C26H27NO2 | |||
| Purity: | ≥ 98% | |||
| Shipping: | Room temperature |
| Item Name: | AM2201 | |||
| Description: | A potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the CB1 and CB2 receptors | |||
| Formal Name: | [1-(5-fluoropentyl)-1H-indol-3-yl]-1-naphthalenyl-methanone | |||
| Molecule Formula: | C24H22FNO | |||
| Purity: | ≥ 98% | |||
| Shipping: | Wet ice |
| Item Name: | AM2201-d5 | ||
| Description: | Contains five deuterium atoms at the 2, 4, 5, 6, and 7 positions | ||
| Formal Name: | [1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl-2,4,5,6,7-d5]-1-naphthalenyl-methanone | ||
| Formulation: | A solution in methanol | ||
| Purity: | ≥ 99% deuterated | ||
| Shipping: | Wet ice |
| Item Name: | AM2201 N-(4-hydroxypentyl) metabolite | |||
| Description: | Is an expected urinary metabolite of AM2201, based on the known metabolism of similar compounds | |||
| Formal Name: | (1-(5-fluoro-4-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | |||
| Molecule Formula: | C24H22FNO2 | |||
| Purity: | ≥ 98% | |||
| Shipping: | Room temperature |
| Item Name: | JWH 007 | |||
| Description: | A potent cannabinoid (CB) receptor agonist that avidly binds to both CB1 and CB2 (Ki = 9.5 and 2.9 nM | |||
| Formal Name: | (2-methyl-1-pentyl-1H-indol-3-yl)-1-naphthalenyl-methanone | |||
| Molecule Formula: | C25H25NO | |||
| Purity: | ≥ 98% | |||
| Shipping: | Room temperature |
| Item Name: | JWH 007-d9 | |||
| Description: | Contains nine deuterium atoms at the 2, 2’, 3, 3’, 4, 4’, 5, 5, and 5 positions | |||
| Formal Name: | (2-methyl-1-pentyl-1H-indol-3-yl)-1-naphthalenyl-2,2,3,3,4,4,5,5,5-d9-methanone | |||
| Molecule Formula | C25H16D9NO | |||
| Purity: | ≥ 99% deuterated | |||
| Shipping: | Wet ice |
| Item Name: | UR144 N-pentanoic acid metabolite | |||
| Description: | Expected phase I metabolite of UR-144 | |||
| Formal Name: | 5-(3-(2,2,3,3-tetramethylcycloporpanecarbonyl)-1H-indol-l-yl)pentanoic acid | |||
| Molecule Formula | C21H27NO3 | |||
| Purity: | ≥ 98% | |||
| Shipping: | Room temperature |
| Item Name: | AB-FUBINACA | |||
| Description: | A potent cannabinoid (CB) receptor agonist that avidly binds to both CB1 and CB2 | |||
| Formal Name: | N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indaole-3-carboxamide | |||
| Molecule Formula | C20H21FN4O2 | |||
| Purity: | ≥ 98% | |||
| Shipping: | Room temperature |
| Item Name: | MAB-CHMINACA | |||
| Description: | Indazole-based synthetic cannabinoid with a high affinity ligand of the CB1 receptor | |||
| Formal Name: | N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | |||
| Molecule Formula | C21H30N4O2 | |||
| Purity: | ≥ 98% | |||
| Shipping: | Room temperature |
| Item Name: | AKB48 | |||
| Description: | Quinolones with adamantyl-carboxamide moieties eith high affinity for the peripheral CB2 receptor but greatly reduced affinity for CB1 | |||
| Formal Name: | 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide | |||
| Molecule Formula | C23H31N3O | |||
| Purity: | ≥ 98% | |||
| Shipping: | Room temperature |
| Item Name: | AKB48-d9 | |||
| Description: | Contains nine deuterium atoms at the 2, 2’, 3, 3’, 4, 4’, 5, 5, and 5 positions | |||
| Formal Name: | 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-2,2,3,3,4,4,5,5,5-d9-carboxamide | |||
| Molecule Formula | C23H22D9N3O | |||
| Purity: | ≥ 99% deuterated | |||
| Shipping: | Wet ice |
SUPPLIES AND PRICES
1. AGREEMENT
1.1 The acquisition represents an other than full and open competition in accordance with FAR Part 6 with a NAICS code is 325119.
1.2 The resultant Blanket Purchase Agreement (BPA) will be on a DD 1155 which will not include any Contract Line Item Numbers (CLINS). Therefore, there are no CLINS included on this soliciations.
1.3 The Government intends to award one Blanket Purchase Agreement (BPA) contract, but may award multiple. Requirements will be procured via the award of call orders issued against the basic agreement(s). The minimum for each awardee is $500. 00. The maximum value of all call orders issued as result of this solicitation is $1,200,000.00
2. EXTENT OF OBLIGATIONS
2.1 The Government is obligated only to the extent of authorized purchases ordered and received under the resultant BPA.
2.2 Ordering Officers with a Government Purchase Card (GPC) are limited to $25,000.00 for each Call Order. All orders above $25,000.00 will be issued by a USAMRAA KO on a call order.
3. ISSUANCE OF CALL ORDERS
3.1 All Synthetic Cannabinoid deliveries under the resultant BPAs will be set forth in individual Call Orders. All Orders will be issued in accordance with (IAW) the requirements and all clauses listed in this soliciation.
3.2 The anticipated collective maximum amount of all Call Orders issued against the resultant BPAs for the base plue five (4) option years will not exceed $1,200,000.00 per section 9 of BPA ADMINISTRATION
3.3 Issuance of verbal or oral Orders are authorized under the resultant BPA for the GPC Ordering Officers and the USAMRAA Contracting Officer. Call Orders issued by the USAMRAA Contracting Officer will be on the DD 1155 or SF 1449.
STATEMENT OF NEED
Synthetic Cannabinoids Statement of Need
1. Scope
1.1. This award provides for the purchase of Syntheric Cannabinoids to support the Armed Forces Medical Examiner System (AFMES), Division of Forensic Toxicology’s (DFT). DFT’s primary function is to provide forensic toxicology testing and consultation for all Department of Defense (DoD) air, ground, and sea based mishap investigations, and criminal investigations. It also provides fitness for duty investigations, and medico-legal determinations (e.g., DUI) and other special cases of national interest. The laboratory serves as the central forensic toxicology laboratory for the entire DoD by providing drug analyses. In addition, the laboratory provides analysis on concentration determinations for therapeutic or toxic doses of drugs and special study investigations for emerging drugs of abuse. It is the only DoD laboratory capable of providing analytical testing for the newest and the fastest emerging drugs of abuse in the military – synthetic cannabinoids known as “Spice” and designer cathinones, known as “Bath Salts”. Spice and Bath Salt compounds are prohibited for use in the United States IAW 21 CFR Part 1308; however, they are controlled under the Drug Enforcement Administration (DEA), Schedule 1 controlled substance
1.2. The supply Statement of Need (SON) has been reviewed and contains no supplies and services that are inherently grovernmental functions, as defined in the Federal Acquisition Regualtion (FAR) Part 2.1. The general scope of this supply requirement is to procure supplies required to support the AFMES mission at the customers location in Dover AFB, DE.
1.3. This BPA is available for use by the entire DoD medical community. However please refer to the authorized ordering offices listed below. Delivery shall be made based on the delivery instructions provided at the time each Call Order is issued.
2. OBJECTIVE
2.1. The objective of this single award BPA requirement is to purchase Ampules containing neat solutions or dried material are used in the preparation of calibrators, standards and/or control materials. These materials are used to quantitate many of the frequently analyzed synthetic cannabinoids and also the non-frequently analyzed drugs reported by the AFMES. Additionally, material within the ampule is often used as reference material when obtaining full scan mass spectral data in medico-legal investigations. As a neat solution this material is assayed by gas chromatography/ mass spectrometry (GC/MS) Liquid Chromatography/ Mass Spectrometry (LC/MS), and Liquid Chromatography tandem mass spectrometry (LC/MS/MS). Material which is sealed in ampules and soluble in an organic solvent is also used as a retention time standard or markers when identifying compounds of interest when extracted from a biological matrix
The following is a sample list of supplies to be purchased on the BPA:
| JWH 122 |
| JWH 122-d9 |
| JWH 122 N-(5-hydroxypentyl) metabolite |
| RCS-4 |
| RCS-4-d9 |
| RCS-4-N-(5-hydroxypentyl) metabolite |
| RCS-4-N-(4-hydroxypentyl) metabolite |
| RCS-4-N-(5-carboxypentyl) metabolite |
| JWH 250 |
| JWH 250-d5 |
| JWH 250 N-(4-hydroxypentyl) metabolite |
| JWH 250 N-( (pentanoic acid) metabolite |
| JWH 250 N-(5-hydropentyl) metabolite |
| JWH 210 |
| JWH 210-d9 |
JWH 210 N-(pentanoic acid) metabolite
| JWH 210 N-(5-hydroxypentyl) metabolite |
| AM2201 |
| AM2201-d5 |
| AM2201 N-(4-hydroxypentyl) metabolite |
| JWH 007 |
| JWH 007-d9 |
| UR144 N-pentanoic acid metabolite |
| AB-FUBINACA |
| MAB-CHMINACA |
| AKB48 |
| AKB48-d9 |
3. Period and Place of Delivery Requirements
3.1. The proposed Period of Performance for the resultant BPA is a Base Period of one year plus four ( 4) one year Option Periods beginning on or about 2 May 2017.
3.2. Place of delivery. The primary delivery location will be AFMES, 115 Purple Heart Drive, Dover AFB, DE 19902. However, as the resultant BPA will be open to the entire DoD medical community, multiple delivery locations could be expected.
4. Inspection and Acceptance
4.1. Certification by the Government of satisfactory goods provided is contingent upon the vendor performing in accordance with the terms and conditions of the resultant BPA and all Call Orders issued against the BPA. Items will be returned to the vendor is they do not meet specifications specified in the Call Order at receipt inspection.
4.2 The Government point of contact (POC) may reject or require correction of any deficiencies found in the invoice or receiving report. In the event of a rejected invoice or receiving report, the vendor will be notified in writing by the Government POC with the specific reasons for rejection.
5. Authorized Agencies
The following offices are hereby authorized to place Orders under the resultant BPAs:
U.S. Army Medical Research Acquisition Activity (USAMRAA) 820 Chandler Street Fort Detrick, MD 21702
Armed Forces Medical Examiner System (AFMES) 115 Purple Heart Drive Dover AFB, DE 19902
The USAMRAA Contracting Officer and Government Purchase Card (GPC) Ordering Officers will be the only authorized buyers under this BPA. USAMRAA will be authorized to place Orders for other agencies under the Medical Research Material Command and other DoD medical agencies, as needed. The position titles of the appointed GPC Ordering Officers will be provided at the time of BPA award.
Orders by other individuals will not be honored without prior written approval from the USAMRAA Contracting Officer.
6. Contractor Quarterly Report
The contractor shall provide an electronic quarterly report of GPC Orders within 15 calendar days after the close of each quarter (31 March; 30 June; 30 Spetember; 31 December). The reports shall include Orders placed from the first day of the quarter to the last day of the quarter. Reports shall reflect, at a minimum, the following information:
Unique Order Number Date of Order Item Description(s) Total Dollar Amount of Each Order Authorized Ordering Official’s Name
If no GPC Orders were made in a given quarter, the contractor shall send a report or email stating such. Reports shall be sent via email to Kimberly Hannan at kimberly.s.hannan.civ@mail.mil
7. Applicable Documents and Definitions
Compliance Documents. The following documents provides specifications, standards, or guidelines that must be complied with in order to meet the requirements of this soliciation.
8. Deliverables
The contractor shall provide electronic copies of the deliverables as described in the below table and in accordance with submission requirements. Deliverables shall be specified by the Government.
| Item |
| Reference |
| Title |
| Distribution |
| Submission Requirements |
| 1 |
| SON, Section 6 |
| Quarterly GPC Order Report |
| Contract Specialist |
| Quarterly, within 15 calendar days after the close of each quarter. |
BPA ADMINISTRATION
1. PAYMENT
Payment procedures will be indicated on each Call Order
2. CONTRACTING OFFICER’S REPRESENTATIVE (COR)
The COR for the resultant BPA will be assigned via a separate appointment letter.
3. BPA MANAGEMENT
It is the contractor’s responsibility to notify the Contracting Officer (KO) immediately if there are any administrative changes such as contact information. Additionally, the contractor shall immediately contact the KO to request clarification when a question arises regarding the authority of any person to act for the KO under the resultant BPA.
4. INTERPRETATION OF MODIFICATION
No verbal or written statement by any person other than the KO, or his/her authorized representative acting within the scope of his/her authority, shall be interpreted as modifying or otherwise affecting the terms of this solicitation as the resultant BPA. All requests for amendments/modifications shall be made in writing to the KO or Contract Specialist.
5. SITE VISITS
The Government reseves the right to conduct an onsite visit to the offerors location to determine if the facility meets the requirements.
6. ORGANIZATIONAL CONFLICT OF INTEREST (OCI)
If any OCI arises during the Period of Performance, the vendor shall notify the Contracting Officer in writing. Please be advised that the Government may not make an award that would result in a prohibited OCI. Therefore, offerors shall identify any and all potential OCI that arises from performing any aspects of the requirement as detailed in the SON and MECs, and included proposed means of preventing, avoiding or mitigating each OCI identified.
7. ANNUAL BPA REVIEWS
The resultant BPA will be reviewed annually, in accordance with FAR 13.303-6 to ensure that authorized procedures are being followed and to determine if updates and/or modifications to existing terms and conditions are appropriate.
8. CALL ORDERS
8.1. The contractor shall perform in accordance with the agreement schedule and as called for by Orders issued in accordance with the following procedures.
8.2. The DD 1155 will be used to issue Call Order assignments and to signify Contracting Officer notification to commence work under the individual Call Orders. The contract shall not proceed with the Call Order assignments until notification is received from the Contracting Officer or authorized GPC Ordering Officers.
8.3. The Call Orders, and modifications to Call Orders, will be numbered by the issuing office. Modifications to the Call Order will be designated by the modification number and contain the original Call Order number.
8.4. The contractor shall identify all correspondence, reports, drawings, and other pertinent papers in connection with the BPA by imprinting thereon the Call Order and the BPA number, plus any other references furnished by the Contracting Officer. Note that the BPA number will follow this format: W81XWH-17-A-XXXX.
8.5. The total of all completed and outstanding Call Orders will at no time exceed the current amount of obligated funds.
8.6. The Competition Advocate for the U.S. Army Medical Research Material Command, Fort Detrick, Maryland has beed designated as the Ombudsman for this BPA.
8.7. Procedures:
8.7.1. Prior to issuance of a Call Order and upon definition of the Government requirement either
a. The Contract Specialist will, in writing, issue to the contractor a Call Order Request for Quote (RFQ), or
b. an authorized GPC Ordering Officer will, in writing or verbally, issue to the contractors a Call Order RFQ.
8.7.2. The contractor shall provides its Call Order quote to the Contract Specialist or authorized GPC Ordering Officer by a date mutually agreed upon but no later than five (5) working days after receipt of the RFQ, unless otherwise specified.
9. BPA CEILING
The cumulative ceiling price of the BPA issued against this solicitation will be $1,200,000.00. The contractor agrees that the work performed under the resultant BPA shall be accomplished within the specified ceiling price. Unless and until the Contracting Officer has notified the contractor in writing that the ceiling price has been increased and the amount of the increase, any cost incurred in excess of the ceiling price shall be borne by the contractor. Contractor entitlment to the monies specified as the BPA ceiling is derived solely from the issuance and successful performance of Call Orders against that ceiling amount.
DELIVERY INFORMATION
| CLIN |
| DELIVERY DATE |
| QUANTITY |
| SHIP TO ADDRESS |
| DODAAC |
CLAUSES INCORPORATED BY REFERENCE
| 52.203-3 |
| Gratuities |
| APR 1984 |
| 52.203-11 |
| Certification And Disclosure Regarding Payments To Influence Certain Federal Transactions |
| SEP 2007 |
| 52.203-12 |
| Limitation On Payments To Influence Certain Federal Transactions |
| OCT 2010 |
| 52.204-4 |
| Printed or Copied Double-Sided on Postconsumer Fiber Content Paper |
| MAY 2011 |
| 52.204-7 |
| System for Award Management |
| OCT 2016 |
| 52.204-13 |
| System for Award Management Maintenance |
| OCT 2016 |
| 52.204-16 |
| Commercial and Government Entity Code Reporting |
| JUL 2016 |
| 52.204-18 |
| Commercial and Government Entity Code Maintenance |
| JUL 2016 |
| 52.204-19 |
| Incorporation by Reference of Representations and Certifications. |
| DEC 2014 |
| 52.215-20 |
| Requirements for Certified Cost or Pricing Data or Information Other Than Certified Cost or Pricing Data |
| OCT 2010 |
| 52.216-27 |
| Single or Multiple Awards |
| OCT 1995 |
| 52.219-9 |
| Small Business Subcontracting Plan |
| JAN 2017 |
| 52.219-9 (Dev) |
| Small Business Subcontracting Plan (Deviation 2016-O0009) |
| JAN 2017 |
| 52.225-25 |
| Prohibition on Contracting with Entities Engaging in Certain Activities or Transactions Relating to Iran-- Representation and Certifications. |
| OCT 2015 |
| 52.227-1 |
| Authorization and Consent |
| DEC 2007 |
| 52.229-3 |
| Federal, State And Local Taxes |
| FEB 2013 |
| 52.232-17 |
| Interest |
| MAY 2014 |
| 52.232-37 |
| Multiple Payment Arrangements |
| MAY 1999 |
| 52.232-39 |
| Unenforceability of Unauthorized Obligations |
| JUN 2013 |
| 52.232-40 |
| Providing Accelerated Payments to Small Business Subcontractors |
| DEC 2013 |
| 52.233-4 |
| Applicable Law for Breach of Contract Claim |
| OCT 2004 |
| 52.242-13 |
| Bankruptcy |
| JUL 1995 |
| 52.242-15 |
| Stop-Work Order |
| AUG 1989 |
| 52.246-2 |
| Inspection Of Supplies--Fixed Price |
| AUG 1996 |
| 52.247-34 |
| F.O.B. Destination |
| NOV 1991 |
| 52.249-8 |
| Default (Fixed-Price Supply & Service) |
| APR 1984 |
| 52.253-1 |
| Computer Generated Forms |
| JAN 1991 |
| 252.201-7000 |
| Contracting Officer's Representative |
| DEC 1991 |
| 252.203-7000 |
| Requirements Relating to Compensation of Former DoD Officials |
| SEP 2011 |
| 252.203-7002 |
| Requirement to Inform Employees of Whistleblower Rights |
| SEP 2013 |
| 252.203-7005 |
| Representation Relating to Compensation of Former DoD Officials |
| NOV 2011 |
| 252.204-7003 |
| Control Of Government Personnel Work Product |
| APR 1992 |
| 252.204-7004 Alt A |
| System for Award Management Alternate A |
| FEB 2014 |
| 252.204-7006 |
| Billing Instructions |
| OCT 2005 |
| 252.204-7012 |
| Safeguarding Covered Defense Information and Cyber Incident Reporting |
| OCT 2016 |
| 252.204-7015 |
| Notice of Authorized Disclosure of Information for Litigation Support |
| MAY 2016 |
| 252.209-7004 |
| Subcontracting With Firms That Are Owned or Controlled By The Government of a Country that is a State Sponsor of Terrorism |
| OCT 2015 |
| 252.215-7008 |
| Only One Offer |
| OCT 2013 |
| 252.219-7003 |
| Small Business Subcontracting Plan (DOD Contracts)--Basic |
| MAR 2016 |
| 252.225-7001 |
| Buy American And Balance Of Payments Program-- Basic (Dec 2016) |
| DEC 2016 |
| 252.225-7021 |
| Trade Agreements--Basic |
| DEC 2016 |
| 252.225-7036 |
| Buy American--Free Trade Agreement--Balance of Payments Program--Basic (DEC 2016) |
| DEC 2016 |
| 252.225-7048 |
| Export-Controlled Items |
| JUN 2013 |
| 252.225-7050 |
| Disclosure of Ownership or Control by the Government of a Country that is a State Sponsor of Terrorism |
| OCT 2015 |
| 252.232-7003 |
| Electronic Submission of Payment Requests and Receiving Reports |
| JUN 2012 |
| 252.232-7010 |
| Levies on Contract Payments |
| DEC 2006 |
| 252.243-7001 |
| Pricing Of Contract Modifications |
| DEC 1991 |
| 252.243-7002 |
| Requests for Equitable Adjustment |
| DEC 2012 |
| 252.244-7000 |
| Subcontracts for Commercial Items |
| JUN 2013 |
| 252.246-7000 |
| Material Inspection And Receiving Report |
| MAR 2008 |
| 252.247-7023 |
| Transportation of Supplies by Sea |
| APR 2014 |
CLAUSES INCORPORATED BY FULL TEXT
52.204-17 OWNERSHIP OR CONTROL OF OFFEROR (JUL 2016)
(a) Definitions. As used in this provision--
Commercial and Government Entity (CAGE) code means—
(1) An identifier assigned to entities located in the United States or its outlying areas by the Defense Logistics Agency (DLA) Commercial and Government Entity (CAGE) Branch to identify a commercial or government entity; or
(2) An identifier assigned by a member of the North Atlantic Treaty Organization (NATO) or by the NATO Support and Procurement Agency (NSPA) to entities located outside the United States and its outlying areas that the DLA Commercial and Government Entity (CAGE) Branch records and maintains in the CAGE master file. This type of code is known as a NATO CAGE (NCAGE) code.
Highest-level owner means the entity that owns or controls an immediate owner of the offeror, or that owns or controls one or more entities that control an immediate owner of the offeror. No entity owns or exercises control of the highest level owner.
Immediate owner means an entity, other than the offeror, that has direct control of the offeror. Indicators of control include, but are not limited to, one or more of the following: Ownership or interlocking management, identity of interests among family members, shared facilities and equipment, and the common use of employees.
(b) The Offeror represents that it [ ___ ] has or [ ___ ] does not have an immediate owner. If the Offeror has more than one immediate owner (such as a joint venture), then the Offeror shall respond to paragraph (c) and if applicable, paragraph (d) of this provision for each participant in the joint venture.
(c) If the Offeror indicates ``has'' in paragraph (b) of this provision, enter the following information:
Immediate owner CAGE code:
Immediate owner legal name: ___
(Do not use a ``doing business as'' name)
Is the immediate owner owned or controlled by another entity?:
[ ___ ] Yes or [ ___ ] No.
(d) If the Offeror indicates ``yes'' in paragraph (c) of this provision, indicating that the immediate owner is owned or controlled by another entity, then enter the following information:
Highest-level owner CAGE code:
Highest-level owner legal name:
(Do not use a ``doing business as'' name)
(End of provision)
52.212-1 INSTRUCTIONS TO OFFERORS--COMMERCIAL ITEMS (JAN 2017)
(a) North American Industry Classification System (NAICS) code and small business size standard. The NAICS code and small business size standard for this acquisition appear in Block 10 of the solicitation cover sheet (SF 1449). However, the small business size standard for a concern which submits an offer in its own name, but which proposes to furnish an item which it did not itself manufacture, is 500 employees.
(b) Submission of offers. Submit signed and dated offers to the office specified in this solicitation at or before the exact time specified in this solicitation. Offers may be submitted on the SF 1449, letterhead stationery, or as otherwise specified in the solicitation. As a minimum, offers must show--
(1) The solicitation number;
(2) The time specified in the solicitation for receipt of offers;
(3) The name, address, and telephone number of the offeror;
(4) A technical description of the items being offered in sufficient detail to evaluate compliance with the requirements in the solicitation. This may include product literature, or other documents, if necessary;
(5) Terms of any express warranty;
(6) Price and any discount terms;
(7) "Remit to" address, if different than mailing address;
(8) A completed copy of the representations and certifications at FAR 52.212-3 (see FAR 52.212-3(b) for those representations and certifications that the offeror shall complete electronically);
(9) Acknowledgment of Solicitation Amendments;
(10) Past performance information, when included as an evaluation factor, to include recent and relevant contracts for the same or similar items and other references (including contract numbers, points of contact with telephone numbers and other relevant information); and
(11) If the offer is not submitted on the SF 1449, include a statement specifying the extent of agreement with all terms, conditions, and provisions included in the solicitation. Offers that fail to furnish required representations or information, or reject the terms and conditions of the solicitation may be excluded from consideration.
(c) Period for acceptance of offers. The offeror agrees to hold the prices in its offer firm for 30 calendar days from the date specified for receipt of offers, unless another time period is specified in an addendum to the solicitation.
(d) Product samples. When required by the solicitation, product samples shall be submitted at or prior to the time specified for receipt of offers. Unless otherwise specified in this solicitation, these samples shall be submitted at no expense to the Government, and returned at the sender's request and expense, unless they are destroyed during preaward testing.
(e) Multiple offers. Offerors are encouraged to submit multiple offers presenting alternative terms and conditions, including alternative line items (provided that the alternative line items are consistent with subpart 4.10 of the Federal Acquisition Regulation), or alternative commercial items for satisfying the requirements of this solicitation. Each offer submitted will be evaluated separately.
(f) Late submissions, modifications, revisions, and withdrawals of offers:
(1) Offerors are responsible for submitting offers, and any modifications, revisions, or withdrawals, so as to reach the Government office designated in the solicitation by the time specified in the solicitation. If no time is specified in the solicitation, the time for receipt is 4:30 p.m., local time, for the designated Government office on the date that offers or revisions are due.
(2)(i) Any offer, modification, revision, or withdrawal of an offer received at the Government office designated in the solicitation after the exact time specified for receipt of offers is “late” and will not be considered unless it is received before award is made, the Contracting Officer determines that accepting the late offer would not unduly delay the acquisition; and--
(A) If it was transmitted through an electronic commerce method authorized by the solicitation, it was received at the initial point of entry to the Government infrastructure not later than 5:00 p.m. one working day prior to the date specified for receipt of offers; or
(B) There is acceptable evidence to establish that it was received at the Government installation designated for receipt of offers and was under the Government's control prior to the time set for receipt of offers; or
(C) If this solicitation is a request for proposals, it was the only proposal received.
(ii) However, a late modification of an otherwise successful offer, that makes its terms more favorable to the Government, will be considered at any time it is received and may be accepted.
(3) Acceptable evidence to establish the time of receipt at the Government installation includes the time/date stamp of that installation on the offer wrapper, other documentary evidence of receipt maintained by the installation, or oral testimony or statements of Government personnel.
(4) If an emergency or unanticipated event interrupts normal Government processes so that offers cannot be received at the Government office designated for receipt of offers by the exact time specified in the solicitation, and urgent Government requirements preclude amendment of the solicitation or other notice of an extension of the closing date, the time specified for receipt of offers will be deemed to be extended to the same time of day specified in the solicitation on the first work day on which normal Government processes resume.
(5) Offers may be withdrawn by written notice received at any time before the exact time set for receipt of offers. Oral offers in response to oral solicitations may be withdrawn orally. If the solicitation authorizes facsimile offers, offers may be withdrawn via facsimile received at any time before the exact time set for receipt of offers, subject to the conditions specified in the solicitation concerning facsimile offers. An offer may be withdrawn in person by an offeror or its authorized representative if, before the exact time set for receipt of offers, the identity of the person requesting withdrawal is established and the person signs a receipt for the offer.
(g) Contract award (not applicable to Invitation for Bids). The Government intends to evaluate offers and award a contract without discussions with offerors. Therefore, the offeror's initial offer should contain the offeror's best terms from a price and technical standpoint. However, the Government reserves the right to conduct discussions if later determined by the Contracting Officer to be necessary. The Government may reject any or all offers if such action is in the public interest; accept other than the lowest offer; and waive informalities and minor irregularities in offers received.
(h) Multiple awards. The Government may accept any item or group of items of an offer, unless the offeror qualifies the offer by specific limitations. Unless otherwise provided in the Schedule, offers may not be submitted for quantities less than those specified. The Government reserves the right to make an award on any item for a quantity less than the quantity offered, at the unit prices offered, unless the offeror specifies otherwise in the offer.
(i) Availability of requirements documents cited in the solicitation. (1)(i) The GSA Index of Federal Specifications, Standards and Commercial Item Descriptions, FPMR Part 101-29, and copies of specifications, standards, and commercial item descriptions cited in this solicitation may be obtained for a fee by submitting a request to--GSA Federal Supply Service Specifications Section, Suite 8100, 470 East L'Enfant Plaza, SW, Washington, DC 20407, Telephone (202) 619-8925, Facsimile (202) 619-8978.
(ii) If the General Services Administration, Department of Agriculture, or Department of Veterans Affairs issued this solicitation, a single copy of specifications, standards, and commercial item descriptions cited in this solicitation may be obtained free of charge by submitting a request to the addressee in paragraph (i)(1)(i) of this provision. Additional copies will be issued for a fee.
(2) Most unclassified Defense specifications and standards may be downloaded from the following ASSIST websites:
(i) ASSIST (https://assist.dla.mil/online/start/).
(ii) Quick Search (http://quicksearch.dla.mil/).
(iii) ASSISTdocs.com (http://assistdocs.com).
(3) Documents not available from ASSIST may be ordered from the Department of Defense Single Stock Point (DoDSSP) by--
(i) Using the ASSIST Shopping Wizard (https://assist.dla.mil/wizard/index.cfm);
(ii) Phoning the DoDSSP Customer Service Desk (215) 697-2179, Mon-Fri, 0730 to 1600 EST; or
(iii) Ordering from DoDSSP, Building 4, Section D, 700 Robbins Avenue, Philadelphia, PA 19111-5094, Telephone (215) 697-2667/2179, Facsimile (215) 697-1462.
(4) Nongovernment (voluntary) standards must be obtained from the organization responsible for their preparation, publication, or maintenance.
(j) Unique entity identifier. (Applies to all offers exceeding $3,500, and offers of $3,500 or less if the solicitation requires the Contractor to be registered in the System for Award Management (SAM) database.) The Offeror shall enter, in the block with its name and address on the cover page of its offer, the annotation ``Unique Entity Identifier'' followed by the unique entity identifier that identifies the Offeror's name and address. The Offeror also shall enter its Electronic Funds Transfer (EFT) indicator, if applicable. The EFT indicator is a four-character suffix to the unique entity identifier. The suffix is assigned at the discretion of the Offeror to establish additional SAM records for identifying alternative EFT accounts (see subpart 32.11) for the same entity. If the Offeror does not have a unique entity identifier, it should contact the entity designated at www.sam.gov for unique entity identifier establishment directly to obtain one. The Offeror should indicate that it is an offeror for a Government contract when contacting the entity designated at www.sam.gov for establishing the unique entity identifier.
(k) System for Award Management. Unless exempted by an addendum to this solicitation, by submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the SAM database prior to award, during performance and through final payment of any contract resulting from this solicitation. If the Offeror does not become registered in the SAM database in the time prescribed by the Contracting Officer, the Contracting Officer will proceed to award to the next otherwise successful registered Offeror. Offerors may obtain information on registration and annual confirmation requirements via the SAM database accessed through https://www.acquisition.gov.
(l) Debriefing. If a post-award debriefing is given to requesting offerors, the Government shall disclose the following information, if applicable:
(1) The agency's evaluation of the significant weak or deficient factors in the debriefed offeror's offer.
(2) The overall evaluated cost or price and technical rating of the successful and the debriefed offeror and past performance information on the debriefed offeror.
(3) The overall ranking of all offerors, when any ranking was developed by the agency during source selection.
(4) A summary of the rationale for award;
(5) For acquisitions of commercial items, the make and model of the item to be delivered by the successful offeror.
(6) Reasonable responses to relevant questions posed by the debriefed offeror as to whether source-selection procedures set forth in the solicitation, applicable regulations, and other applicable authorities were followed by the agency.
ADDENDUM TO 52.212-1
ADDITIONAL INSTRUCTIONS TO OFFERORS
1. TECHNICAL QUESTIONS AND PRE-PROPOSAL DISCUSSION
Questions concerning the solicitation are due no later than 13 April 2017 at 10:00 A.M Eastern Time. Questions shall be submitted to Ms. Kim Hannan at kimberly.s.hannan.civ@mail.mil and the USAMRAA Materiel 1 mailbox at usarmy.detrick.medcom-usamraa.mbx.materiel1@mail.mil. An amendment to the solicitation will be posted in order to address the questions received; however, no questions will be addressed after the cutoff date and time listed above. Please note that only one (1) set of question will be accepted by the Government
2. INSTRUCTIONS FOR THE PREPARATION AND SUBMISSION OF PROPOSALS
Failure to submit all documents concurrently and in accordance with these instructions may render a proposal unacceptable. The proposal shall be submitted electronically via email to kimberly.s.hannan.civ@mail.mil and the USAMRAA Materiel 1 mailbox at usarmy.detrick.medcom-usamraa.mbx.materiel1@mail.mil no later than 19 Aptil 2017 at 10:00 AM Eastern Daytime Time.
3. PROPOSAL EVALUATION
To aid in evaluation, proposals shall be practical, specific complete, and logically assembled. The proposal shall be in a clear, concise format satisfying all requirements of this solicitation. It shall be in sufficient detail to demonstrate a complete understanding of the work to be accomplished.
4. THE PROPOSAL
The overall proposal shall consist of three (3) separate volumes, individually titled. Each volume shall be appropriately titled, as follows:
| Volume Number |
| Volume Title |
| Volume I |
| Technical Proposal |
| Volume II |
| Price Proposal |
| Volume III |
| Administrative Documents |
Volume I shall be broken up into four (4) sections: Executed Solicitation Documents, Executive Summary, Technical, and Past Performance information (excluding the completed past performance questionnaires submitted from past performance references). The entirety of Volume I, should not exceed fifty (50) pages, including appendices, matrices, and tables. Fold-outs (either 8 ½” by 14” or 11” x 17”) shall count as two (2) pages each. Proposals shall be typed in 12-point, Times New Roman font using 1” margins on the top, bottom and sides. Graphics, tables and matrices are exempt from the 12-point font requirement. The Table of Contents, Solicitation (executed copy of this SF1449 and any amendments), tabs and index sheets will not be counted towards the page limits listed above. Any pages exceeding the page limitation or any pages containing materials not legible to the evaluators will be disregarded and will not be evaluated.
There are no page limitations for Volume II of the proposal. However, an electronic copy of the Offeror’s Commercial Published Price List, including any additional discounts off of their current pricing, shall be submitted as part of Volume II.
4.1. Contents of the Technical Proposal (Volume I)
All sections of the Offeror’s Technical Proposal shall make direct reference to the AFMES Synthetic Cannabinoids SON (located on page 3 of this solicitation) and MECs (located on page 6 of this solicitation) section paragraph numbers, if applicable. The Proposal shall be presented in a clear and logical order. Statements such as “will comply”, “meets the intent of”, or “we intend to meet the requirements” and the like, will not suffice for evaluation purposes.
Section 1 – Executed Solicitation Documents (SF 1449) Section 1 shall contain a signed copy of the SF1449 and signed amendments (if any).
Section 2 – Technical Acceptability In Section 3, the Offer shall clearly demonstrate that it has a clear understanding of the requirements outlined in the SON (located on page 3 of this solicitation) and MECs (located on page 6 of this solicitation). The Offeror’s proposal shall include all required documentation detailed in the list below.
A copy of the Offeror’s commercial QCP which will serve as the functional QCP explaining in detail the manner in which the Offeror will maintain quality control for these products. This QCP should include processes to ensure timely and successful performance of this acquisition. If the offeror does not have a commercial QCP then a QCP shall be developed and submitted for this specific requirement and included in this volume.
4.2. Contents of the Price Proposal (Volume II)
The Offeror shall provide a Price Proposal to include the following items:
Electronic copy of the Offeror’s Commercial Published Price List for Human Identification Reagents Test Kits and Consumables Supplies (including any additional discounts off of its current pricing);
The Offeror’s Price Proposal to include all of the aforementioned items will be incorporated into the resultant BPA award. The Offeror is encouraged to propose additional discounts off of their Published Price List for this Blanket Purchase Agreement. Please indicate the discount amounts within your proposal for review. After award of the base BPA, the Offeror may propose additional discounted price(s) to the Government in response to Call Order Request for Quotes. Call Order total values however, shall not exceed the individual Call Order limitations established in the Master BPA.
4.3. Contents of the Administrative Documents (Volume III)
4.3.1. Small Business Subcontracting Plan (SBSP): All Offerors except U.S. Small Business Offerors shall submit a Small Business Subcontracting Plan that addresses all factors in FAR 52.219-9 (Dev) FAR 52.219-9 Alt II (Dev) and DFARS 252.219-7003 (Dev). The SBSP will be used to determine contractor responsibility. In addition to the SBSP, Offerors shall certify compliance with FAR Clause 52.209-6 and provide sufficient information for the Government to determine responsibility of its proposed subcontractors.
The Small Business Subcontracting Plan is not a requirement for evaluation in source selection, but rather, a requirement for award to a large business and will be incorporated into any resultant BPA.
The Offeror shall submit a SBSP that addresses the following mandatory elements as found…
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .